400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2021-07-21
——
医药研发/制造
化学&生物药
Sectoral Asset Management;
Sectoral Asset Management;
Point72 Ventures;
Point72 Ventures;
Teralys Capital;
Eventide Asset Management;
Ridgeback Capital;
奥博资本;
PFM Health Sciences;
Sixil Degree Capital;
Brace Pharma Capital;
CaaS;
F-Prime Capital;
Takeda Ventures;
Versant Ventures;
Northleaf Capital Partners;
Surveyor Capital
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10